Argomenti trattati
January showcased significant developments in the health technology sector, with numerous companies announcing substantial funding rounds. This increase in financing underscores the growing emphasis on health tech innovations aimed at improving patient care and operational efficiency. Here, we explore some of the standout funding achievements from this month.
OpenEvidence secures $250 million in Series D funding
OpenEvidence, a prominent player in the health tech landscape, has successfully raised $250 million in its latest Series D funding round. The company focuses on delivering an AI-driven medical search and decision-support platform that provides healthcare professionals with real-time, evidence-based answers derived from peer-reviewed literature and clinical guidelines. Currently, more than 10,000 hospitals and medical practices across the United States utilize its advanced search engine.
This funding round, co-led by Thrive Capital and DST Global, elevates OpenEvidence’s total fundraising to nearly $700 million. The company intends to use these funds to bolster research and development efforts, particularly addressing the computational demands linked to its multi-AI agent framework.
Zarminali Pediatrics raises $110 million in Series A funding
Founded in 2026, Zarminali Pediatrics has rapidly established itself as a provider of essential primary and specialty healthcare services for children, serving patients from infancy through their teenage years. Operating 28 clinics across eight states, the company offers a variety of services, including routine check-ups and immediate sick care.
The recent Series A funding round generated $110 million, led by Healthier Capital, with participation from General Catalyst and K2 HealthVentures. This brings Zarminali’s total capital raised to over $150 million. The financing will enable Zarminali to enhance its technology platform and expand its services, including the opening of 15 new clinics in key markets such as Chicago, Milwaukee, and Dallas, as well as extending services to urgent care and specialized therapies like speech, occupational, and behavioral therapy.
Pomelo Care achieves $92 million in Series C funding
Based in New York City, Pomelo Care is making significant strides in the health tech sector, having secured $92 million in its Series C funding round. The company serves a diverse demographic by providing support for pregnancy, pediatrics, midlife, and women’s health. Users benefit from 24/7 virtual assistance via the Pomelo app, which offers access to a dedicated care team and customized care plans.
By leveraging predictive analytics, Pomelo Care enables clinicians to identify potential health issues early and respond effectively. The company collaborates with insurers and employers, currently serving a population of 25 million lives through partnerships with commercial and Medicaid health plans. The Series C funding was led by Stripes, with contributions from notable investors such as Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel. With a new valuation of $1.7 billion, Pomelo has raised a total of $171.2 million, which will be directed toward enhancing clinical teams, technology infrastructure, and partnerships.
Apella raises $80 million in funding
Apella, a specialist in ambient video intelligence, has successfully raised $80 million through a Series B equity and venture debt round. This innovative platform provides hospitals with real-time operational insights, helping to minimize delays and streamline processes. By integrating ambient AI with electronic health record (EHR) data, Apella automates essential tasks such as coordination, scheduling, and staffing.
The funding round was led by HighlandX, with participation from Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, Operator Partners, K2 HealthVentures, OpAmp Capital, and Houston Methodist. This financial boost will support Apella in enhancing its technological capabilities and expanding its influence within the health sector.
The funding achievements in January reflect the vitality of the health tech sector and indicate a promising future for innovation in healthcare. As these companies continue to evolve, their contributions are expected to lead to significant advancements in patient care and operational efficiency.